Series E funding round for Apellis Pharmaceuticals raising $60M in August 2017
Series E funding round for Apellis Pharmaceuticals raising $60M in August 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$60M
Top Valuation
-
Apellis Pharmaceuticals raised $60M in a Series E round.
The round was announced on 08/01/17.